Furthermore, our studies suggest that MEIS2 downregulates the expression of IL10 to suppress breast cancer growth, and MEIS2‐IL10 signaling is partially associated with MDSCs infiltration in BC. This evidence concerns the gene IL10 and breast carcinoma.